Outcomes 2017 - Baylor Heart and Vascular Services FY2017 | Page 86

CLINICAL TRIALS and studies

Takotsubo Cardiomyopathy Registry. Primary Investigator: Jeffrey M. Schussler, MD
TEE Indication and Post Procedure Management – Indication and Post Procedure Management Changes of Trans-Esophageal Echocardiography. Primary Investigator: Jeffrey M. Schussler, MD
Tendyne – Early Feasibility Study of Tendyne Bioprosthetic Mitral Valve System Primary Investigator: Paul A. Grayburn, MD, Robert F. Hebeler, Jr., MD
The Well-Being of Chronic Disease Patients and their Family Caregivers – An Assessment of Emotional and Spiritual Health – A survey study to gain insight into the complex relationships between patients with chronic diseases, the family members who care for them, and the role of religion. Primary Investigator: Kristen Tecson, PhD
Therapeutic Intensity of Lipid Lowering Therapy in Response to Recurrent Cardiovascular Events – A large retrospective database study to determine the patterns of medical management before and after cardiovascular events. Primary Investigators: Peter McCullough, MD, Kristen Tecson, PhD
Timing of Coronary Angiography and MARCE – Timing of Coronary Angiography and Multivariate Risk for Cardiac Surgery Associated Acute Kidney Injury and Major Adverse Renal and Cardiac Events( MARCE). Primary Investigator: Peter A. McCullough, MD
Total QRS Voltage in Cardiac Sarcoidosis. Primary Investigator: William C. Roberts, MD
Transient AV Block with Cryoablation – Clinical characteristics of Transient AV Block with cryoablation. Primary Investigator: Peter Wells, MD
Type A Aortic Dissections – Outcomes Following Type A Aortic Dissections: the Baylor University Medical Center Experience. Primary Investigator: Brian Lima, MD
Umbrella Protocol – Studies Utilizing Data from Baylor Cardiovascular Databases. Primary Investigator: Anupama Vasudevan, MD
USPella – A Multi-Center, Data Registry Study designed to collect data from subjects that have been treated using the IMPELLA 2.5 circulatory device per institution’ s standard of care. Primary Investigator: Robert Stoler, MD
Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction( HFrEF) – VerlCiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction Primary Investigator: Peter A. McCullough, MD
VOYAGER – An international, multicenter, randomized, double-blind, placebo-controlled phase 3 trial investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization procedures. Primary Investigator: William Shutze, MD
Women’ s Experiences during an Acute Myocardial Infarction. Primary Investigator: Dena Allen
World-wide Randomized Antibiotic Envelope Infection Prevention Trial. Primary Investigator: Jay Franklin, MD
ZENITH – Zenith TX2 TAA endovascular graft postmarket approval study. Primary Investigator: William Shutze, MD
THRASOS – A Phase II Multi-Center, Parallel-Group, Randomized, Double Blind, Proof-of-Concept, Adaptive Study Investigating the Safety and Efficacy of THR- 184 Administered via Intravenous Infusion. Primary Investigators: Robert F. Hebeler, MD, Sub-investigator: Cara East, MD
VEST – The Vest Prevention of Early Sudden Death Trial( VEST). Primary Investigator: Jay Franklin, MD
VICTORIA – A Randomized Parallel-Group, Place- Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trail of Efficacy and

CARDIOVASCULAR RELATED SCIENTIFIC PUBLICATIONS( FY17)

MEASURING INNOVATION IN HEART AND VASCULAR CARE
1. Adesina GO, Hall SA, Mendez JC, Joseph SM, Gottlieb RL, Kale PP, Bindra AS. Arrthmogenic Right Ventricular Dysplasia: An Under-recognized Form of Inherited Cardiomyopathy. Reviews in Cardiovascular Medicine 2017; 18( 1): 37-43.
2. Afzal A, Sarmast S, Choi JW, McCullough PA, Schussler JM. Spontaneous Coronary Artery Dissection: A Review of Pathogenesis, Presentations, Treatment, and Outcomes. Reviews in Cardiovascular Medicine 2017; 18( 1): 29-36.
3. Ailawadi G, Chang HL, O’ Gara PT, O’ Sullivan K, Woo YJ, DeRose JJ, Parides MK, Thourani VH, Robichaud S, Gillnov AM, Taddei-Peters WC, Miller MA, Perrault LP, Smith RL, Goldsmith L, Horvath KA, Doud K, Baio K, Gelijns AC, Moskowitz AJ, Begiella E, Alexander JH, Iribarne A. Pneumonia after cardiac surgery: Experience of the National Institutes of Health / Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network. The Journal of Thoracic and Cardiovascular Surgery Jun 2017; 153( 6): 1384-1391.
4. Ali AT, Rueda M, Desikan S, Moursi MM, An R, Spencer H, Rueda S, Eidt JF. Outcomes after retroflexed gracilis muscle flap for vascular infections in the groin. Journal of Vascular Surgery 2016 Aug; 64( 2): 452-457; Epub 2016 May 14.
5. Arsalan M, Agricola E, Alfieri O, Baldus S, Colombo A, Filardo G, Hammerstingl C, Huntgeburth M, Kreidel F, Kuck KH, LaCanna G, Messika- Zeitoun D, Maisano F, Nickenig G, Pollock BD, Roberts BJ, Vahanian A, Grayburn PA. Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral Annulus. American Journal of Cardiology 2016 Sep 1; 118( 5): 744-9. Epub 2016 Jun 15.
6. Arsalan M, Squiers JJ, Filardo G, Pollock B, DiMaio JM, Prava B, Gopal A, Mahoney AC, Brown DL, Mack MJ, Grayburn PA. Effect of Elliptical LV Outflow Tract Geometry on Classification of Aortic Stenosis in a Multidisciplinary Heart Team Setting. JACC: Cardiovascular Imaging. Jan 2017; In press.
7. Arsalan M, Squiers JJ, Herbert MA, MacHannaford JC, Chamogeorgakis T, Prince SL, Hamman BL, Knoff C, Moore DO, Harrington KB, DiMaio JM, Mack MJ, Brinkman WT. Comparison of Outcomes of Operative Therapy for Acute Type A Aortic Dissections Provided at High-Volume Versus Low- Volume Medical Centers in North Texas. The American Journal of Cardiology Jan 2017; 119( 2): 323-327.
8. Arsalan M, Walther T, Smith RL, Grayburn PA. Tricuspid regurgitation diagnosis and treatment. European Heart Journal March 2017; 38( 9): 634-638.
9. Baumgarten H, Squiers JJ, Brinkman BT, Vasquez J. Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm After Coarctation Operation. The Annals of Thoracic Surgery Feb 2017; 103( 2): e167-e169.
10. Becker TM, Grayburn PA, Roberts WC. Mitral Valve Repair for Pure Mitral Regurgitation Followed Years Later by Mitral Valve Replacement for Mitral Stenosis. American Journal of Cardiology Jul 2017; 120( 1): 160-166.
11. Benjamin MM, Afzal A, Chamogeorgakis T, Feghali GA. Right atrial thrombus and its causes, complications, and therapy. Proceedings Baylor University Medical Center Jan 2017; 30( 1): 54-56.
12. Blackbourne BD, Vasudevan A, Roberts WC. Comparison at Necropsy of Heart Weight in Women Aged 20 to 29 Years With Fatal Trauma of Chemical Intoxication Versus Fatal Natural Cause( A Search for the Normal Adult Heart Weight). American Journal of Cardiology Mar 2017; 119( 5): 808-812.
13. Blanke P, Park JK, Grayburn P, Naoum C, Ong K, Kohli K, Norgaard BL, Webb JG, Popma J, Boshell D, Sorajja P, Muller D, Leipsic J. Left ventricular access point determination for a coaxial approach to the mitral annular landing zone in transcatheter mitral valve replacement. Journal of Cardiovascular Computed Tomography Apr 2017; Epub.
14. Bohm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Packer M, McMurray JJV. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril / valsartan( LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. European Heart Journal Apr 2017; 38( 15): 1132-1143.
15. Cannon JA, Shen L, Jhund PS, Kristensen SL, Kober L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV, on behalf of the PARADIGM-HF Investigators and Committees. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. European Journal of Heart Failure Jan 2017; 19( 1): 129-137.
16. Capoulade R, Zeng X, Overbey JR, Ailawadi G, Alexander JH, Ascheim D, Bowdish M, Gelijns AC, Grayburn P, Kron IL, Levine RA, Mack MJ, Melnitchouk S, Michler RE, Mullen JC, O ' Gara P, Parides MK, Smith P, Voisine P, Hung J; Cardiothoracic Surgical Trials Network( CTSN) Investigators. Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty. Circulation. 2016 Oct 25; 134( 17): 1247-1256.
17. Carey SA, Bass K, Saracino G, East CA, Felius J, Grayburn PA, Vallabhan RC, Hall SA. Probability of Accurate Heart Failure Diagnosis and the Implications for Hospital Readmissions. The American Journal of Cardiology Apr 2017; 119( 7): 1041-1046.
18. Castro MDM, Cossio A, Velasco C, Osorio L. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study. PLoS Negl Trop Dis. Apr 2017; 11( 4). eCollection Apr 2017.
19. Cedars A, Benjamin L, Burns SV, Novak E, Amin A. Clinical predictors of length of stay in adults with congenital heart disease. Heart. 2017 Feb 25.
20. Cedars A, Opotowsky AR. Sustaining Happiness in Adult Congenital Heart Disease. World Journal for Pediatric and Congenital Heart Surgery. 2016 Sep; 7( 5): 635-7.
21. Cedars A, Burns S, Novak EL, Amin AP. Predictors of Rehospitalization Among Adults With Congenital Heart Disease Are Lesion Specific. Circulation: Cardiovascular Quality and Outcomes. 2016 Sep; 9( 5): 566-75. Epub 2016 Sep 13.
84